A New Vision Of Anatomic Pathology
ChemImage’s Raman Molecular Imaging (RMI) approach enables objective assessment of tissues and cells without the use of stains or reagents. Our advanced imaging techniques result in what we call a "digital stain", a chemometric image of tissue that we can interpret using computational science as well as visual observation. This technology provides a significant advantage across the scope of pathological study, including
cellular apoptosis,
digital pathology,
fluorescence imaging—even the study of
prostate and
kidney cancer.
Since traditional pathological evaluation of tissues and cells involves a somewhat subjective evaluation of spatially complex stained tissue samples, accurate interpretation of pathology specimens can be very challenging for a number of tissue and disease types. Yet pathologists have to base their treatment decisions on the accuracy of that evaluation.
Raman Molecular Imaging using the Falcon II™ Provides:
- Molecular specificity
- Sensitivity to subtle molecular differences
- Measurement of Raman signals from the molecular constituents of a sample without reagents
- Measurements that are spatially localized within a given sample
Raman molecular images are acquired from tissue samples illuminated by a laser in a microscope. The images are analyzed using chemometric-based classification algorithms to objectively classify the sample in terms of disease state. RMI for anatomic pathology can be applied to a number of specific health-related cellular challenges.